Ivermectin, which is the active ingredient in Iverheal 12 mg, is not typically used or approved for treating benign prostatic hyperplasia (BPH). BPH is a condition where the prostate gland enlarges and can cause urinary symptoms such as frequent urination, urgency, weak urine stream, and others. The effectiveness of Iverheal 12 mg, or any form of ivermectin, in treating BPH has not been established through clinical research or medical guidelines. Treatment for BPH typically involves medications such as alpha-blockers (e.g., tamsulosin) or 5-alpha-reductase inhibitors (e.g., finasteride), or in some cases, surgical interventions. If you are experiencing symptoms of BPH, it is important to consult with a healthcare professional who can provide appropriate diagnosis and treatment options based on your individual health needs.